venture capital

Biotech startup Allena Pharma raises $15M
Bizjournals.com
Wed, 11/16/11 - 09:47 am
Allena Pharma
venture capital
Series A
Veryan raises venture capital
Tue, 11/1/11 - 11:16 pm
Veryan
venture capital
VCs align with med-tech makers to lobby for change in FDA review process
Wed, 10/26/11 - 10:25 pm
FDA
law
venture capital
Venture Capitalists Put Money on Easing Medical Device Rules
Tue, 10/25/11 - 10:48 pm
venture capital
Venture Firms Reduce Biotechnology Investment on FDA Risk
Thu, 10/6/11 - 10:25 pm
venture capital
biotech
FDA
investment
Debunking Corporate Venture Capital in Biotech
Forbes
Sun, 09/25/11 - 01:05 pm
venture capital
Merck's $500 Million Venture Bet -- Industry's Latest and Largest Attempt to Get Closer to VCs
InVivo
Fri, 09/16/11 - 12:41 pm
Merck
venture capital
Merck Research Venture Fund
VC investment up in San Diego life science hub
Thu, 08/11/11 - 11:12 pm
venture capital
San Diego
science
Venture Investing In Biotech Continues To Drop
Pharmalot
Thu, 08/11/11 - 11:13 am
biotech
venture capital
Biotechnology Bounces Back With 46% Rise in Venture Capital
Bloomberg
Wed, 07/20/11 - 11:22 am
venture capital
biotech
Venture Capital: Medical device startups don't need it
Fri, 05/27/11 - 03:18 pm
venture capital
Venture backers inject $25M into Synageva's rare disease platform
Fierce Biotech
Mon, 03/21/11 - 01:40 pm
venture capital
Synageva
Lysosomal Acid Lipase deficiency
Biotech VC investing grows 3% in 2010
Fierce Biotech
Fri, 01/21/11 - 12:32 pm
biotech
venture capital
Symphogen lines up record $131M venture round
Fierce Biotech
Fri, 01/7/11 - 07:24 am
Symphogen
venture capital
Venture Firms Feel The Pain With GlaxoSmithKline Spin-Off
WSJ Online
Tue, 10/5/10 - 07:00 am
venture capital
GSK
Convergence Pharmaceuticals
Third Rock leads $30M round for antibody upstart CytomX
Fierce Biotech
Thu, 09/23/10 - 07:55 am
CytomX
venture capital
antibodies
Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg
Thu, 09/9/10 - 06:34 am
Eli Lilly
venture capital
drug development
Top 5 Biotech VC Deals of 2010
Fierce Biotech
Wed, 07/28/10 - 11:35 pm
venture capital
biotech
Tesaro
Archimedes Pharma
Achaogen
NGM Biopharmaceuticals
Neurotherapeutics Pharma
Antidepressant Maker Euthymics Bioscience Taps $24 Million
NY Times, NY
Fri, 07/23/10 - 09:14 am
Euthymics Bioscience
antidepressants
venture capital
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics
Xconomy
Mon, 07/19/10 - 09:39 am
Achaogen
financing
antibiotics
venture capital

Pages